Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
₩35.80K - ₩61.90K
Next Earnings Date
May 12 2025
Next Earnings Date
May 12 2025
Latest price
Market Cap | ₩3.15T |
EV | ₩2.61T |
Shares Outstanding | 78.35M |
Beta | 1.18 |
Analyst Rating | UNDERPERFORM |
Analyst Target Price | ₩44000.00 |
P/E 2025E | - |
P/Revenue 2025E | 4.76x |
Revenue | -34.00% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 28.20% |
EPS | -1.50% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 27.70% |
Net Profit Margin 2025E | -5.69% |
ROE 2025E | -2.89% |
ROCE 2024 | -3.07% |
DPS 2025E | ₩0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
SK bioscience Co.,Ltd.
A302440
Sector
Healthcare
Industry
Biotechnology
CEO
Ahn, Jae-Yong
Employees
984
Website
www.skbioscience.co.krIPO Date
2021-03-18
Headquarters
310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, South Korea
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved